Evidence map›Paper›PMID 32130656›Full record

ArticleTranslational stroke research2020

PSD-93 Interacts with SynGAP and Promotes SynGAP Ubiquitination and Ischemic Brain Injury in Mice.

Qingxiu Zhang, Hui Yang, Hong Gao, Xiaomei Liu, Qingjie Li, Rong Rong, Zhenqian Liu, Xiu-E Wei, Liping Kong, Yun Xu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Activity-Dependent Stabilization of Nascent Dendritic Spines Requires Nonenzymatic CaMKIIα Function.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cyfip1 Regulates SynGAP1 at Hippocampal Synapses.Frontiers in synaptic neuroscience · 2020
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Qingxiu Zhang *Department of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China.
Hui Yang *Department of Neurosurgery, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Hong GaoDepartment of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China.
Xiaomei LiuDepartment of Pathogenic Biology and Immunology, Lab of Infection and Immunity, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
Qingjie LiDepartment of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Rong RongDepartment of Neurology, Drum Tower Hospital of Nanjing Medical University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, People's Republic of China.
Zhenqian LiuDepartment of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China.
Xiu-E WeiDepartment of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China.
Liping KongDepartment of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China.
Yun XuDepartment of Neurology, Drum Tower Hospital of Nanjing Medical University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, People's Republic of China. xuyun20042001@aliyun.com.
Liangqun RongDepartment of Neurology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Coal Road, Xuzhou, 221006, Jiangsu, People's Republic of China. rongliangqun@163.com.
Xuzhou Medical College · CNNanjing Medical University · CN

Funding

the National Natural Science Foundation of China 81671149 and 81301120the National Natural Science Foundation of China 81971179the Natural Science Foundation of Jiangsu Province BK20191463the Natural Science Foundation of of Jiangsu Province BK20151168the Natural Science Foundation of of Jiangsu Province BK20161167the Natural Science Foundation of the Colleges and Universities in Jiangsu Province 13KJB320027the Xuzhou Medical Young Talents Project -
6 · The paper itself

Abstract

Postsynaptic density protein-93 (PSD-93) plays an important role in ischemic brain injury through N-methyl-D-aspartate receptor (NMDAR)-triggered neurotoxicity. GTPase-activating protein for Ras (SynGAP) is a GAP specifically expressed in the central nervous system to regulate nerve development and synaptic plasticity. However, the link between PSD-93 and SynGAP and their role in ischemic brain injury remain elusive. Here, we showed that PSD-93 interacted with SynGAP and mediated SynGAP ubiquitination and degradation following ischemic brain injury. Proteasome inhibitor MG-132 could reverse the decrease of SynGAP protein level in wild-type mice following cerebral ischemia reperfusion through inhibiting SynGAP ubiquitination. Furthermore, NMDA receptor inhibitor MK801 could increase SynGAP protein level in wild-type mice following cerebral ischemia reperfusion. However, in PSD-93 knockout mice, MG-132 or NMDAR inhibitor had no significant effect on SynGAP expression. Both MG-132 and PSD-93 knockout reduced infarct volume and improved neurological deficit in mice at different time points after cerebral ischemia reperfusion. Furthermore, we identified that 670-685 amino acid sequence of SynGAP was essential to the binding of SynGAP to PSD-93, and designed a fusion peptide Tat-SynGAP (670-685aa) that could attenuate ischemic brain damage in wild-type mice. In conclusion, we provide the first evidence that PSD-93 directly interacts with SynGAP and mediates its ubiquitination and degradation to aggravate ischemic brain damage. Tat-SynGAP (670-685aa) may be considered as a candidate for treatment of acute ischemic stroke.

Indexed as

UbiquitinationAnimalsBrain IschemiaGTPase-Activating ProteinsGuanylate KinasesInfarction, Middle Cerebral ArteryMaleMembrane ProteinsMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsNeuronal PlasticityStrokeDlg2 protein, mouseGTPase-Activating ProteinsGuanylate KinasesMembrane ProteinsNerve Tissue Proteinspostsynaptic density proteinsIschemic brain injuryNeuronal excitotoxicityPSD-93SynGAPUbiquitination

Identifiers

PMID32130656
OpenAlexW3010223387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.